Clinical Trial Update: Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating population pharmacokinetics and safety of intravenous ceftolozane/tazobactam in adult cystic fibrosis patients, completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Cystic Fibrosis Pulmonary Exacerbation
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Ceftolozane/Tazobactam (ceftolozane/tazobactam)

Snippet

Sponsor: Joseph L. Kuti, PharmD | Conditions: Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | Phase 4 | Status: COMPLETED | Results posted: 2017-04-13